N-[6-(morpholin-4-ylmethyl)pyridin-2-yl]-2-[3-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridine-8-carboxamide | 1198169-70-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三唑并吡啶类
• 英文名称: N-[6-(morpholin-4-ylmethyl)pyridin-2-yl]-2-[3-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridine-8-carboxamide
• CAS: 1198169-70-8
• 化学式: C₂₄H₂₁F₃N₆O₃
• 分子量: 498.464
• InChiKey: WINCAEMFXMINTO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  36
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  93.9
• 氢给体数：
  1
• 氢受体数：
  10

文献信息

• IMIDAZOPYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS
  申请人：Vu Chi B.

  公开号：US20110077248A1

  公开（公告）日：2011-03-31

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了一种新的调节sirtuin的化合物及其使用方法。这些调节sirtuin的化合物可用于增加细胞寿命，治疗和/或预防各种疾病和障碍，包括与衰老或压力有关的疾病或障碍、糖尿病、肥胖症、神经退行性疾病、心血管疾病、血液凝块障碍、炎症、癌症和/或潮红，以及需要增加线粒体活性的疾病或障碍。还提供了含有调节sirtuin的化合物和另一种治疗剂的组合物。